Vaccinology Consulting provides advice and consulting services to industry and university laboratories with vaccine and biologics projects preparing to enter clinical development or in early stage clinical development. The probability of success in later stages of development can be improved by making the right decisions early of how to characterize a vaccine or biologic in preclinical stages, and measure its effectiveness in early clinical studies.Vaccinology Consulting will perform a comprehensive review of the methods used to characterize your product and to measure its effectiveness in preclinical and clinical studies. We will provide a risk assessment to identify potential problem areas, and recommend strategies to minimize downstream risk as your product enters early clinical development. If desired, Vaccinology Consulting can provide oversight and specific recommendations as you develop test methods to reduce your technical risk and maximize the value of your project to potential corporate partners.